Bioactive products generated by Group V sPLA2 hydrolysis of LDL activate macrophages to secrete pro-inflammatory cytokines
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Phospholipase A 2 –Modified Low-Density Lipoprotein Activates Macrophage Peroxisome Proliferator–Activated ReceptorsArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Syndecan-4 mediates macrophage uptake of group V secretory phospholipase A2-modified LDLJournal of Lipid Research, 2009
- LDL cholesteryl oleate as a predictor for atherosclerosis: evidence from human and animal studies on dietary fatJournal of Lipid Research, 2009
- The Capacity of Group V sPLA 2 to Increase Atherogenicity of ApoE −/− and LDLR −/− Mouse LDL In Vitro Predicts its Atherogenic Role In VivoArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- 5-Fluoro-2-indolyl des-chlorohalopemide (FIPI), a Phospholipase D Pharmacological Inhibitor That Alters Cell Spreading and Inhibits ChemotaxisMolecular Pharmacology, 2009
- Autotaxin/Lysopholipase D and Lysophosphatidic Acid Regulate Murine Hemostasis and ThrombosisJournal of Biological Chemistry, 2009
- Analyses of Group III Secreted Phospholipase A2 Transgenic Mice Reveal Potential Participation of This Enzyme in Plasma Lipoprotein Modification, Macrophage Foam Cell Formation, and AtherosclerosisJournal of Biological Chemistry, 2008
- Biology of Secretory Phospholipase A2Cardiovascular Drugs and Therapy, 2008
- Atherogenic properties of LDL particles modified by human group X secreted phospholipase A2 on human endothelial cell functionThe FASEB Journal, 2006
- Inflammation in atherosclerosisNature, 2002